Showing results (111-120 of 152) with videos related to
Sort By:
Pageof 16
Molecules (Basel, Switzerland)|February 12, 2020
Radiosynthesis of [<sup>18</sup>F]-Labelled Pro-Nucleotides (ProTides)Alessandra Cavaliere, Katrin C Probst, Stephen J Paisey, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2018
IRAK1 Limits TLR3/4- and IFNAR-Driven IL-27 Production through a STAT1-Dependent MechanismDaniela Bruni, Adam Dignam, Susan Dunne, et al.Journal of Medicinal Chemistry|November 14, 2008
Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularineChristine B Yoo, Rocco Valente, Costantino Congiatu, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 3, 2024
Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registryKerstin Hellwig, David Rog, Christopher McGuigan, et al.Antimicrobial Agents and Chemotherapy|February 9, 2012
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirinChristophe Vanpouille, Andrea Lisco, Andrea Introini, et al.Journal of Neuroimmunology|December 8, 2024
A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodiesMichael Gilligan, Luke O'Donnell, Andrew Westbrook, et al.Journal of Medicinal Chemistry|April 17, 2012
Novel phosphoramidate prodrugs of N-acetyl-(D)-glucosamine with antidegenerative activity on bovine and human cartilage explantsMichaela Serpi, Rita Bibbo, Stephanie Rat, et al.Journal of Medicinal Chemistry|October 5, 2007
First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virusPlinio Perrone, Felice Daverio, Rocco Valente, et al.The Journal of Infectious Diseases|January 21, 2010
A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Christophe Vanpouille, Andrea Lisco, Marco Derudas, et al.The Journal of Antimicrobial Chemotherapy|July 21, 2020
Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobialsFabrizio Pertusati, Elisa Pileggi, Jennifer Richards, et al.Pageof 16